Emerging Pharma

Built for Emerging Pharma

Launch expertise built for companies preparing for their first commercial success.

Emerging biotech companies face a unique moment: transforming breakthrough science into a successful commercial launch.

This transition requires more than traditional agency support. It demands a partner who understands regulatory complexity, stakeholder ecosystems, and the operational realities of bringing a therapy to market.

Built for Emerging Pharma Launches

At Perigord, we work exclusively in life sciences. We help emerging pharma companies build the strategic, scientific, and communication foundations required to move from clinical innovation to commercial adoption.

Making Complex Science Clear, Credible and Compliant

Our teams combine scientific expertise, regulatory precision, and creative excellence to translate complex science into clear, compliant, and compelling communications that engage healthcare professionals, patients, and payers.

Supporting Your First Commercial Launch

Emerging biotech companies face the challenge of turning breakthrough science into a successful commercial launch. At Perigord, we help build the strategic, scientific, and communication foundations needed to bring new therapies to market with clarity, confidence, and regulatory precision.

Launch Strategy and Market Preparation

We help emerging companies prepare the market long before regulatory approval by building the strategic foundations for adoption.

Scientific Platform and Medical Communications

Successful launches begin with a strong scientific story.

Brand Strategy and Creative Communications

Defining brand architecture and communication platform.

Omnichannel Engagement, Digital Platforms and Analytics

Launch success requires coordinated engagement across audiences and channels.

Supporting Global Launch Infrastructure

Perigord operates exclusively within the life sciences sector.

We combine deep scientific understanding with regulatory expertise, ensuring every deliverable aligns with global standards including FDA, EMA, and MLR requirements. This specialist focus enables us to translate complex science into clear, compliant communications that support successful product launches and sustained commercial growth.

Our quality systems align with GxP and GMP best practices, ensuring compliant content creation and the secure management of sensitive healthcare data across global markets.

Meet the Team

Our teams bring extensive experience across the life sciences landscape — from understanding the science behind the therapy to navigating the commercial realities of bringing it to market.

Working closely with medical, regulatory, market access, and commercial stakeholders, we ensure every communication is scientifically credible, strategically aligned, and relevant to the real-world environments where therapies are prescribed, reimbursed, and delivered.

Gary Orr
CCO & Global Head of ESG
Gabriele Iannizzotto
Chief Business Officer
Nickey Ratcliffe
Client Director
Lenny Figorski
Head of Consultancy
Jarek Podoba
Creative Director

Starting a new project or want to know more about what we can offer?

Our team is ready to support you at every stage.